Autolus Therapeutics Mean Deviation
| AUTL Stock | | | USD 1.65 -0.05 -2.94% |
The mean deviation of the equity instrument is the first measure of the distances between each value of security historical prices and the mean. It gives us an idea of how spread out from the center the distribution of returns. Below is Autolus Therapeutics's current Mean Deviation with peer comparisons and related risk metrics.
Current Mean Deviation Value
At 3.25, Autolus Therapeutics exhibits moderate price variability in Mean Deviation. This places Autolus Therapeutics within the typical volatility range for Biotechnology.
Mean Deviation | = | SUM(RET DEV)N |
| = | 3.25 | |
| SUM | = | Summation notation |
| RET DEV | = | Sum of return deviations of Autolus Therapeutics |
| N | = | Number of calculation points for selected time horizon |
Mean Deviation Peers Comparison
Relative to peers, Autolus Therapeutics's Mean Deviation is below the group average of 3.3. Peer readings range from 2.47 (LB Pharmaceuticals Common) to 4.42 (QuantumSi), reflecting moderate dispersion across the sector. Autolus Therapeutics has exhibited less price dispersion than the peer average over the measured period.
Mean Deviation Relative To Other Indicators
The chart below plots Mean Deviation against Maximum Drawdown for Autolus Therapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Mean Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
The Maximum Drawdown-to-Mean Deviation ratio for Autolus Therapeutics sits near
5.06 , with Mean Deviation at
3.25 and Maximum Drawdown at
16.45 . This indicates Maximum Drawdown substantially exceeds Mean Deviation for Autolus Therapeutics.
Methodology, Assumptions & Data Sources
Autolus Therapeutics has a current Mean Deviation reading of 3.25. Autolus Therapeutics' Mean Deviation is computed from historical closing prices over the selected time horizon, applying the indicator's defined mathematical transformation to raw price data. Inputs are drawn from end-of-day closing prices reported by supported exchanges, adjusted for splits and dividends where applicable. Autolus Therapeutics operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Results are based on historical returns and do not predict future performance. This indicator is provided for informational purposes.
Other Technical Indicators